Insulin pump use in pregnancy is associated with lower HbA1c without increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes

Diabetologia

Volumn 57, Issue 4, 2014, Pages 681-689

  Kallas Koeman, Melissa M ^a   Kong, Jason M ^a   Klinke, Jennifer A ^a   Butalia, Sonia ^b   Lodha, Abhay K ^b   Lim, Ken I ^a   Duan, Qiuli M ^c   Donovan, Lois E ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

Author keywords

Continuous subcutaneous insulin infusion; Diabetes; Insulin pump; Multiple daily injections; Pregnancy; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; MATERNAL CARE; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETINOPATHY; THIRD TRIMESTER PREGNANCY; WEIGHT GAIN;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; PREGNANCY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84896090876     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3163-6     Document Type: Article

References (35)

1. Evers IM, de Valk HW, Visser GHA (2004) Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 328:915-919
2. Pearson DWM, Kernaghan D, Lee R, Penney GC (2007) The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type 1 diabetes mellitus. BJOG 114:104-107 (Pubitemid 44923940)
3. Tripathi A, Rankin J, Aarvold J, Chandler C, Bell R (2010) Preconception counselling in women with diabetes: a population based study in the North of England. Diabetes Care 33:586-588
4. Mukhopadhyay A, Farrell T, Fraser RB, Ola B (2007) Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 197:447-456 (Pubitemid 350007372)
5. Bruttomesso D, Bonomo M, Costa S et al (2011) Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). Diabetes Metab 37:426-431
6. Cyganek K, Hebda-Szydlo A, Katra B et al (2010) Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. Diabetes Technol Ther 12:41-47
7. Chen R, Ben-Haroush A, Weissman-Brenner A, Melamed N, Hod M, Yogev Y (2007) Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 197:404.e1-404.e5
8. Lapolla A, Dalfra MG, Masin M (2003) Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 40:143-149 (Pubitemid 37288124)
9. Gimenez M, Conget I, Nicolau J, Pericot A, Levy I (2007) Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy: a case control study. Acta Diabetol 44:34-37 (Pubitemid 46426961)
10. Gonzalez-Romero S, Gonzalez-Molero I, Fernandez-Abellan Met al (2010) Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes. Diabetes Technol Ther 12:263-269
11. Volpe L, Pancani F, Aragona M et al (2010) Continuous subcutaneous insulin infusion and multiple dose insulin injections in type 1 diabetic pregnant women: a case-control study. Gynecol Endocrinol 26:193-196
12. Wender-Ozegowska E, Zawiejska A, Ozegowska K (2013) Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes. Aust N Z J Obstet Gynaecol 53:130-135
13. Statistics Canada (2006) 2006 Census Dictionary. Statistics Canada, Ottawa, ON, Canada
14. Magee LA, Helewa M, Moutquin JM, von Dadelszen P (2008) Diagnosis, evaluation, andmanagement of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 30:S1-S48
15. Kramer MS, Platt RW, Wen SW (2001) A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108:e35-e41
16. Public Health Agency of Canada (2008) Canadian Perinatal Health Report, 2008 Edition. Public Health Agency of Canada, Ottawa, ON, Canada
17. European Surveillance of Congenital Anomalies (2005) EUROCAT Guide 1.3 and reference documents. EUROCAT Central Registry, Newtownabbey, Northern Ireland, UK
18. Johnson J, Clifton RG, Roberts JM(2013) Pregnancy outcomes with weight gain above or below the 2009 Institute of Medicine Guidelines. Obstet Gynecol 121:969-975
19. Chico A, Saigi I, Garcia-Patterson A et al (2010) Glycemic control and perinatal outcomes of pregnancies complicated by type 1 diabetes: influence of continuous subcutaneous insulin infusion and lispro insulin. Diabetes Technol Ther 12:937-945
20. Persson M, Norman M, Hanson U (2009) Obstetric and perinatal outcomes in type 1 diabetic pregnancies. Diabetes Care 32:2005-2009
21. Wylie BR, Kong J, Kozak SE, Marshall CJ, Tong SO, Thompson DM (2002) Normal perinatal mortality in type 1 diabetesmellitus in a series of 300 consecutive pregnancy outcomes. Am J Perinatol 19:169-176 (Pubitemid 34533564)
22. Jensen DM, Damm P, Moelsted-Pedersen L et al (2004) Outcomes in type 1 diabetic pregnancies. Diabetes Care 27:2819-2823
23. Murphy HR, Rayman G, Lewis K (2008) Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 337:a1680-a1688
24. Kernaghan D, Farrell T, Hammond P, Owen P (2008) Fetal growth in women managed with insulin pump therapy compared to conventional insulin. Eur J Obstet Gynecol Reprod Biol 137:47-49 (Pubitemid 351625437)
25. Kyne-Grzebalski D, Wood L, Marshall SM, Taylor R (1999) Episodic hyperglycaemia in pregnant women with well-controlled type 1 diabetes: a major potential factor underlying macrosomia. Diabet Med 16:702-706
26. Herranz L, Pallardo LF, Hillman N, Martin-Vaquero P, Villarroel A, Fernandez A (2007) Maternal third trimester glycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy. Diabetes Res Clin Pract 75:42-46 (Pubitemid 44856027)
27. Catalano PM, Hauguel-De Mouzon S (2011) Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 204:479-487
28. Kuc S, Wortelboer EJ, Koster MPH, de Valk HW, Schielen PCJI, Visser GHA (2011) Prediction of macrosomia at birth in type-1 and 2 diabetic pregnancies with biomarkers of early placentation. BJOG 118:748-754
29. Maayan-Metzger A, Lubin D, Kuint J (2009) Hypoglycemia rates in the first days of life among term infants born to diabetic mothers. Neonatology 96:80-85
30. Diabetes in Pregnancy Group, France (2003) French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 26:2990-2993
31. Inkster ME, Fahey TE, Donnan PT, Leese GP, Mires GJ, Murphy DJ (2006) Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC Pregnancy Childbirth 6:30-43
32. Jensen DT, Korsholm L, Ovesen P (2009) Peri-conception A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care 32:1046-1048
33. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991-2002
34. Carlsson BM, Andersson PN, Alnervik J, Carstensen J, Lind M (2012) Availability of insulin pump therapy in clinical practice. Diabet Med 29:1055-1059
35. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J (2010) Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev, Issue 1, Art no.: CD005103